Utilisation of autologous transplantation (ASCT) in elderly patients has increased rapidly in the last decade.
Survival increased strongly in the last decade for the general myeloma population.
This effect was even more pronounced in elderly patients treated with ASCT.
ASCT in elderly patients might be a contributor to the seen survival improvement.